Taiwan Society of Cardiology Heart Failure Registry 2020: Rationale and Design

Area of Science:

• Cardiology
• Public Health
• Epidemiology

Background:

• Heart failure (HF) is a global health concern with high mortality and rehospitalization rates.
• Existing Taiwanese HF registries primarily focused on hospitalized patients with heart failure with reduced ejection fraction (HFrEF), limiting generalizability.
• Data on outpatients and patients with heart failure with mildly reduced ejection fraction (HFmrEF) and heart failure with preserved ejection fraction (HFpEF) are scarce.

Purpose of the Study:

• To establish the Taiwan Society of Cardiology Heart Failure Registry 2020.
• To comprehensively assess the epidemiology, guideline adherence, clinical outcomes, and disease progression of Taiwanese HF patients.
• To include diverse HF phenotypes (HFrEF, HFmrEF, HFpEF) and patient populations (inpatients and outpatients).

Main Methods:

• A prospective, multicenter, observational registry enrolling 3,370 HF patients from 27 Taiwanese hospitals (2020-2022).
• Inclusion criteria: acute decompensated HF or recent HF hospitalization.
• Data collection includes demographics, medical history, HF diagnosis, medications, examinations, comorbidities, with 2-year follow-up for clinical outcomes and interventions.

Main Results:

• The registry aims to enroll 3,370 patients with a planned distribution of 59% HFrEF, 13% HFmrEF, and 28% HFpEF.
• Follow-up visits every six months for up to two years.
• Monitoring of clinical outcomes and major cardiac interventions.

Conclusions:

• The Taiwan Society of Cardiology Heart Failure Registry 2020 is a significant initiative.
• It will provide contemporary data on HF management and outcomes in Taiwan.
• The findings will inform clinical practice and public health strategies for heart failure.